FCA Venture Partners Closes Oversubscribed Fund VII at $90 Million

FCA Venture Partners (“FCA”), a leading healthcare technology venture capital firm, is pleased to announce the final close of FCA Venture Partners VII (“FCA VII”), with $90 million in capital commitments, well over the fund’s initial target of $75 million. FCA VII invests in Series A and Series B stage digital health and technology-enabled healthcare services companies that improve patient care, reduce costs, or increase efficiency.

Read More
Virgo and CTNx Partner to Power GI Clinical Trials

Virgo Surgical Video Solutions, Inc. ("Virgo") and The Clinical Trials Network ("CTNx") today announced a strategic partnership to expand and accelerate the identification, selection, and enrollment of patients in GI clinical trials across CTNx's expansive network of 30+ high-quality GI trial sites using Virgo's endoscopy data capture and artificial intelligence platform. 

Read More
HCA Uses AI to Decrease Time From Cancer Diagnosis to First Treatment by Almost a Week

Azra AI offered multiple technologies to help solve the complex problems, beginning with early identification of cancer patients through the use of artificial intelligence to surface positive cancer patients from pathological reports. Azra AI offered the ability to centralize the HCA division's data into essentially one platform from which staff could derive data to set service line goals and growth objectives with real-time data and volumes.

Read More
FCA Venture Partners Closes Oversubscribed Health Innovations II Fund at $71 Million

FCA Venture Partners (“FCA”), a leading healthcare technology venture capital firm, is pleased to announce that FCA Health Innovations II (“FCA HI II”) held its final close with more than $71 million in capital commitments, well over the fund’s initial target of $50 million. With the launch of this fund, FCA HI II will continue its successful strategy in supporting Seed and Series A stage companies within the digital health and technology-enabled healthcare services landscape.

Read More
FCA NewsAndrew Bouldin
CoachCare acquires NVOLVE

CoachCare, a leading remote patient monitoring (RPM) and virtual health company, has acquired Winston-Salem based RPM company NVOLVE, for an undisclosed amount. Founded in 2014, NVOLVE’s expertise in the pain, spine and orthopedic specialties adds providers serving patients across North Carolina, South Carolina, Virginia, Georgia, Texas and Tennessee to CoachCare’s offerings. 

Read More
Industry’s First Male Fertility Platform Posterity Health Raises $7.5M in an Oversubscribed Funding Round Led by Distributed Ventures

Posterity Health, the only digital male fertility center of excellence that offers personalized advice, educational resources, and effective male fertility treatments, today announced an oversubscribed funding round of $7.5M led by early-stage venture capital fund Distributed Ventures. The funding reinforces the importance of evaluating the male partner when a couple is having trouble conceiving. The new capital will accelerate the company’s Digital Health Platform and provide access to male fertility testing and treatment on a national scale. This expansion has been crisply synchronized to capitalize on the new male fertility benefits that became effective on January 1, 2023.

Read More